In a joint statement, the World Health Organization (WHO) and the International Coalition of Medicines Regulatory Authorities (ICMRA) have pledged to take action together to tackle the challenges related to treatments and vaccines against COVID-19.
The two groups reiterated that they are committed to ensuring patients have access to safe and effective medicines and vaccines against COVID-19 as early as possible while maintaining rigorous scientific standards for the evaluation and safety monitoring. Therapeutics and vaccines will only be approved if they are supported by robust and sound scientific evidence showing a positive benefit-risk balance.
Professor Guido Rasi, chair of the ICMRA and executive director of the EMA, said:
“The world is looking at international regulators and WHO to safeguard public health and to coordinate agile regulatory approaches to the COVID-19 response. ICMRA and WHO work closely together to jointly address the challenges related to the development, authorisation and roll-out of safe and effective medicines and vaccines against COVID-19.”
For more information, please read the joint statement.